These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4192886)

  • 21. [Factors affecting plaque formation by Lassa virus in Vero cells].
    Lukashevich IS; Vasiuchkov AD; Mar'iankova RF; Votiakov VI
    Vopr Virusol; 1982; (1):57-61. PubMed ID: 7072230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research on dengue in tissue culture. I. Plaque formation in an established monkey kidney cell line culture.
    Hotta S; Fujita N; Maruyama T
    Kobe J Med Sci; 1966 Sep; 12(3):179-87. PubMed ID: 4962619
    [No Abstract]   [Full Text] [Related]  

  • 23. Simian rotavirus SA-11 plaque formation in the presence of trypsin.
    Ramia S; Sattar SA
    J Clin Microbiol; 1979 Nov; 10(5):609-14. PubMed ID: 94597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes.
    Brandt WE; McCown JM; Top FH; Bancroft WH; Russell PK
    Infect Immun; 1979 Nov; 26(2):534-41. PubMed ID: 121109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adaptability and purification of dengue-III virus D9964 strain in KMB17 cells and proliferation kinetics of adapted strain].
    Zhao YJ; Pan Y; Yan LM; Yue YF; Yang LJ; Chen JY; Ma SH; Shi HJ; Sun QM
    Bing Du Xue Bao; 2013 May; 29(3):287-92. PubMed ID: 23905472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.
    Butrapet S; Huang CY; Pierro DJ; Bhamarapravati N; Gubler DJ; Kinney RM
    J Virol; 2000 Apr; 74(7):3011-9. PubMed ID: 10708415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cell type and virus upon virus-specific immune cytolysis.
    Brandt WE; Russell PK
    Infect Immun; 1975 Feb; 11(2):330-3. PubMed ID: 803470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the interaction between coxsackievirus A9 and HeLa cells. I. Plaque-forming ability of coxsackievirus A9 in HeLa cell cultures.
    Matsumoto M; Nakano M; Nishikawa F; Tagaya I
    Jpn J Med Sci Biol; 1976 Apr; 29(2):67-76. PubMed ID: 184325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.
    Huang CY; Butrapet S; Tsuchiya KR; Bhamarapravati N; Gubler DJ; Kinney RM
    J Virol; 2003 Nov; 77(21):11436-47. PubMed ID: 14557629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of enhancement of virus plaques by cationic polymers.
    Wallis C; Melnick JL
    J Virol; 1968 Apr; 2(4):267-74. PubMed ID: 4986901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Selection of heparin-sensitive dengue virus variants in BHK-21 cells].
    Celis A; Moros Z; Gerder M; Pagano F; Vizzi E; Liprandi F
    Invest Clin; 2014 Jun; 55(2):155-67. PubMed ID: 24974631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells.
    Yuill TM; Sukhavachana P; Nisalak A; Russell PK
    Am J Trop Med Hyg; 1968 May; 17(3):441-8. PubMed ID: 4385131
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolation and propagation of Dengue virus in Vero and BHK-21 cells expressing human DC-SIGN stably.
    Phanthanawiboon S; A-nuegoonpipat A; Panngarm N; Limkittikul K; Ikuta K; Anantapreecha S; Kurosu T
    J Virol Methods; 2014 Dec; 209():55-61. PubMed ID: 25205264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran.
    Pagano JS; McCutchan JH; Vaheri A
    J Virol; 1967 Oct; 1(5):891-7. PubMed ID: 4316237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ionic strength on the release of dengue virus from Vero cells.
    Matsumura T; Stollar V; Schlesinger RW
    J Gen Virol; 1972 Dec; 17(3):343-7. PubMed ID: 4631144
    [No Abstract]   [Full Text] [Related]  

  • 36. Adaptation of the plaque assay methodology for dengue virus infected HepG2 cells.
    Chingsuwanrote P; Suksanpaisan L; Smith DR
    J Virol Methods; 2004 Mar; 116(2):119-21. PubMed ID: 14738977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection of Aedes albopictus Mosquito C6/36 Cells with the
    Teramoto T; Huang X; Armbruster PA; Padmanabhan R
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. IV. Characterization of a vaccine candidate in fetal rhesus lung cells.
    Halstead SB; Eckels KH; Putvatana R; Larsen LK; Marchette NJ
    Am J Trop Med Hyg; 1984 Jul; 33(4):679-83. PubMed ID: 6476215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic characteristics of dengue 2 virus persistently infected in a C6/36 clone of Aedes albopictus cells.
    Chen WJ; Chen SL; Fang AH
    Intervirology; 1994; 37(1):25-30. PubMed ID: 7928286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.
    Huang CY; Butrapet S; Pierro DJ; Chang GJ; Hunt AR; Bhamarapravati N; Gubler DJ; Kinney RM
    J Virol; 2000 Apr; 74(7):3020-8. PubMed ID: 10708416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.